Notice: This company has been marked as potentially delisted and may not be actively trading. NYSE:IMPR Imprivata (IMPR) Stock Price, News & Analysis Add Share Share Stock Analysis Stock Analysis Get Imprivata alerts: Email Address About Imprivata Stock (NYSE:IMPR) 30 days 90 days 365 days Advanced Chart Ad Unstoppable ProsperityMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must.So make sure you claim your free seat by clicking here now. Get Imprivata alerts:Sign Up Key Stats Today's Range$19.26▼$19.2650-Day Range N/A52-Week Range$9.00▼$20.32VolumeN/AAverage Volume258,396 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewImprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.Read More… Must-Know for Trading Options (Ad)Options are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must.So make sure you claim your free seat by clicking here now. Receive IMPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imprivata and its competitors with MarketBeat's FREE daily newsletter. Email Address IMPR Stock News HeadlinesFormer CEO of Carbon Black, Patrick Morley, Joins Bugcrowd's Board of DirectorsSeptember 17 at 9:59 AM | finance.yahoo.comPublic Health At Risk: The Escalating Crisis Of Cyber InequityJuly 31, 2024 | forbes.comForget Trump and KamalaI hope you're deleting all those emails telling you how to make "1,000% gains" from the magic "Kamala Trade". It's nonsense. No one knows what's going to happen in November.September 20, 2024 | Investors Alley (Ad)Imprivata provides untapped, actionable insights into access management with Enterprise Access Management AnalyticsMay 8, 2024 | finance.yahoo.comSecure Messaging in Healthcare Market Size Worth US$ 3,501.6 Million by 2034 at CAGR of 17.4%: Fact.MR ReportApril 24, 2024 | finance.yahoo.comAdvanced Biometrics Industry Analysis Report 2024: Evolution Timeline, Emerging Trends, Patents Landscape, Sector Impacts, Real-world InnovationsApril 22, 2024 | finance.yahoo.comClinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarketsApril 9, 2024 | finanznachrichten.deClinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarkets™April 9, 2024 | finance.yahoo.comSee More Headlines IMPR Stock Analysis - Frequently Asked Questions How were Imprivata's earnings last quarter? Imprivata, Inc. (NYSE:IMPR) released its earnings results on Tuesday, February, 16th. The technology company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.01. The business's revenue was up 17.9% compared to the same quarter last year. What other stocks do shareholders of Imprivata own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imprivata investors own include Teledyne FLIR (FLIR), Allegion (ALLE), Anixter International (AXE), Avigilon (AVO), Ascent Capital Group Inc Series A (ASCMA), ASSA ABLOY AB (publ) (ASAZY) and Applied DNA Sciences (APDN). Company Calendar Last Earnings2/16/2016Today9/20/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:IMPR CUSIPN/A CIK1328015 Webwww.imprivata.com Phone+1-781-6742700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NYSE:IMPR) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imprivata, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imprivata With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.